Endocarditis News and Research

Latest Endocarditis News and Research

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.

2 Jun 2010

Kansas State University researcher awarded NIH grant to study antibiotic-resistant bacteria

Antibiotic-resistant bacteria are becoming a growing problem around the world, and are a particular worry in hospital-acquired infections.

20 May 2010

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

TYRX, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market AIGISRx® ST, its antibacterial product for the surgical repair of damaged or ruptured soft tissue.

28 Apr 2010

New AIGISRx Flat provides antimicrobial protection from CRMD infection

TYRX, Inc. announced today the commercial release of the AIGISRx™ Flat, an antibacterial product that helps provide protection against infections associated with implanted pacemakers and defibrillators.

15 Apr 2010

TYRX begins enrollment in CITADEL study for Aigisrx anti-bacterial agent

TYRX, Inc., a leader in the commercialization of implantable medical devices designed to help reduce infection, announced today that it has begun enrollment in CITADEL, the second of two large scale, prospective, multicenter studies.

24 Mar 2010

FDA looks into supply chain of black and red pepper as part of Salmonella Montevideo investigation

As part of the Salmonella Montevideo investigation, the Food and Drug Administration has been actively investigating the supply chain of black and red pepper supplied to Daniele International Inc., Pascoag, R.I.

15 Mar 2010

Salmonella Montevideo outbreak: FDA investigates Daniele International's pepper supply chain

6 Mar 2010

Possible Salmonella contamination: Mincing Overseas Spice recalls two lots of black pepper

Mincing Overseas Spice Company of Dayton, New Jersey announced today that it is recalling black pepper Lots 3258 and 3309 because of possible contamination with Salmonella.

6 Mar 2010

FDA works closely with different states to investigate the outbreak of Salmonella Montevideo infections

The Food and Drug Administration, along with the Centers for Disease Control and Prevention and the U.S. Department of Agriculture's Food Safety and Inspection Service, continues to work closely with the Rhode Island Department of Health and other states in the investigation of an outbreak of Salmonella Montevideo infections associated with certain Italian-style sausage products including salami/salame.

1 Mar 2010

Early treatment and prevention of gum disease can positively impact many medical conditions

The eyes may be the window to the soul, but research is demonstrating that the mouth is the gateway to good health. In fact, a dental exam can reveal early symptoms of more than 100 diseases, as well as identify gum disease, which can have a negative effect on the body’s overall health.

20 Feb 2010

FDA investigates Salmonella Montevideo outbreak in Italian sausage products

5 Feb 2010

LExICon study evaluating laser assisted lead removal using Spectranetics laser sheath published

Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.

3 Feb 2010

Prometheus Laboratories executes commercialization agreement with Novartis

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a commercialization agreement with Novartis under which Prometheus acquired exclusive rights to distribute, promote and sell PROLEUKIN® (aldesleukin) in the United States.

27 Jan 2010

Transcatheter valve implantation is an effective treatment for patients with aortic stenosis

Research presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), demonstrated an "exceptionally low" rate of complications one year after implantation of transcatheter aortic valve prostheses.

22 Sep 2009

First Analyses of TYRX's AIGISRx Anti-Bacterial Envelope Retrospective Registry

TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices, will present the first analyses of results from its AIGISRx Anti-Bacterial Envelope Retrospective Registry during the Transcatheter Cardiovascular Therapeutics (TCT 2009) meeting in San Francisco, CA.

21 Sep 2009

TYRX to exhibit AIGISRx Anti-Bacterial Envelope at HFSA

TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices, announced today that it will be exhibiting its lead product, AIGISRx Anti-Bacterial Envelope, at the 13th Annual Heart Failure Society of America Meeting (HFSA), in Boston, MA this week.

14 Sep 2009

Clinical data emphasizing on efficacy and potency of torezolid to be presented

Trius Therapeutics, Inc. announced today that 13 posters will be presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) supporting the potency, efficacy and safety of torezolid as a potential new antibiotic for the treatment of severe skin infections caused by gram positive bacteria including MRSA.

14 Sep 2009

FOCUS 1 and FOCUS 2 clinical trial results released

Forest Laboratories, Inc today presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco new data from a complete analysis of FOCUS 1 and FOCUS 2, two global multicenter Phase III studies of ceftaroline for the treatment of community-acquired pneumonia (CAP) in hospitalized patients.

14 Sep 2009

AAN's ability to mimic the human brain helps diagnose cardiac infections

Mayo Clinic researchers say that "teachable software" designed to mimic the human brain may help them diagnose cardiac infections without an invasive exam. Those findings are being presented today at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.

14 Sep 2009

Improved management reduces mortality rates in endocarditis

A clinical study carried out at Hôpital de la Timone in Marseille has demonstrated that a standardized management protocol for patients with infective endocarditis can dramatically reduce mortality rates.

10 Aug 2009

Endocarditis News and Research

Latest Endocarditis News and Research

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Kansas State University researcher awarded NIH grant to study antibiotic-resistant bacteria

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

New AIGISRx Flat provides antimicrobial protection from CRMD infection

TYRX begins enrollment in CITADEL study for Aigisrx anti-bacterial agent

FDA looks into supply chain of black and red pepper as part of Salmonella Montevideo investigation

Salmonella Montevideo outbreak: FDA investigates Daniele International's pepper supply chain

Possible Salmonella contamination: Mincing Overseas Spice recalls two lots of black pepper

FDA works closely with different states to investigate the outbreak of Salmonella Montevideo infections

Early treatment and prevention of gum disease can positively impact many medical conditions

FDA investigates Salmonella Montevideo outbreak in Italian sausage products

LExICon study evaluating laser assisted lead removal using Spectranetics laser sheath published

Prometheus Laboratories executes commercialization agreement with Novartis

Transcatheter valve implantation is an effective treatment for patients with aortic stenosis

First Analyses of TYRX's AIGISRx Anti-Bacterial Envelope Retrospective Registry

TYRX to exhibit AIGISRx Anti-Bacterial Envelope at HFSA

Clinical data emphasizing on efficacy and potency of torezolid to be presented

FOCUS 1 and FOCUS 2 clinical trial results released

AAN's ability to mimic the human brain helps diagnose cardiac infections

Improved management reduces mortality rates in endocarditis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Endocarditis News and Research

Latest Endocarditis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in